Other studies from experimental animal models of RA also demonstrate that antagonizing PI3K/AKT signaling cascades can promote joint inflammation, suggesting that AKT pathway may be a potential therapeutic target for RA [3]. This evidence concerns the gene AKT1 and rheumatoid arthritis.